Skip to main content
. 2021 May 5;10(5):726. doi: 10.3390/antiox10050726
ACTA2 actin alpha 2
AGEs advanced glycation end products
Bfgf basic fibroblast growth factor
CAT catalase
CCL C-C motif chemokine ligand
CX3CL C-X3-C motif chemokine ligand
CXCL C-X-C motif chemokine ligand
CXCR C-X-C motif chemokine receptor
DLK1 delta-like noncanonical Notch ligand 1
DPP4 dipeptidyl peptidase-4
ECM extracellular matrix
EMT epithelial-mesenchymal transition
G-CSF granulocyte colony-stimulating factor
GM-CSF granulocyte/macrophage colony-stimulating factor
GPx glutathione peroxidase
HDFs human dermal fibroblasts
HO-1 heme oxygenase-1
IDH2 isocitrate dehydrogenase (NADP(+))
IGF1 insulin like growth factor 1
IKK inhibitory kappa kinase
IL interleukin
INF γ interferon
ITGA1 integrin subunit alpha 1
Keap1 Kelch-like ECH associated protein 1
LPO lipid peroxidation
MAF musculoaponeurotic fibrosarcoma
MAPKs mitogen-activated protein kinases
MET mesenchymal-epithelial transition
MMPs matrix metalloproteinases
NF-kB nuclear factor kappa-light-chain-enhancer of activated B cells
NLRP3 NLR family pyrin domain containing 3
NQO1 NAD(P)H:quinone oxidoreductase 1
Nrf2 nuclear factors (erythroid-derived 2), factor 2
PDGFR-α platelet derived growth factor receptor alpha
PI3K phosphatidylinositol-3-OH kinase
PTEN reduced phosphatase and tensin homologs
SCA1 spinocerebellar ataxia type 1
SOD superoxide dismutase
TGF-β transforming growth factor
TIMPs tissue inhibitors of metalloproteinase
TLR toll-like receptors
TNF-α tumor necrosis factor